Managed Care Review BoardTM - An Analysis of the Latest Treatments, Economic Value, and Benefit Designs for Multiple Myeloma Live Webcast
Suggested Pre-reading:
Don't miss the free, on-demand CE primer for this activity!
www.ImpactEdu.net/MMPrimer
| DAY | DATE | TIME |
| Tuesday | April 26 | 2:00 PM - 4:00 PM ET |
| Wednesday | May 18 | 12:00 PM - 2:00 PM ET |
| Thursday | May 19 | 1:00 PM - 3:00 PM ET |
| Tuesday | May 24 | 2:00 PM - 4:00 PM ET |
| Monday | July 11 | 12:00 PM - 2:00 PM ET |
|
Joseph Biskupiak, PhD, MBA Research Professor Department of Pharmacotherapy University of Utah College of Pharmacy L.S. Skaggs Pharmacy Institute |
|
Diana Brixner, RPh, PhD, FAMCP Professor, Department of Pharmacotherapy University of Utah College of Pharmacy Executive Director, Outcomes Research Center Director of Outcomes, Program in Personalized Health Care University of Utah Health Sciences Center |
|
Jeffrey Dunn, PharmD, MBA Senior Vice President Chief Clinical Officer VRx Pharmacy Services, LLC |
|
John Fox, MD, MHA Senior Medical Director Associate Vice President, Medical Affairs Priority Health |
|
Shaji Kumar, MD Professor of Medicine Division of Hematology Mayo Clinic |
- Medical Directors and Pharmacy Directors from health plans, HMOs, integrated health systems, employers, quality organizations, and other managed care organizations (MCOs)
- Managed care-affiliated care team members involved with patient evaluation, education, and follow-up for multiple myeloma (MM) including: physicians, pharmacists, registered nurses, and case managers
The treatment paradigm for multiple myeloma (MM) is complex and evolving in light of both the continual introduction of novel agents and regimens, and enhanced patient profiling information. The expanding therapeutic armamentarium presents managed care and specialty pharmacy professionals with the challenge of understanding therapeutic efficacy and tolerability nuances, determining appropriate treatment sequencing and combinations, and evaluating access, coverage, and reimbursement decisions. This live webcast series is designed to provide managed care and specialty pharmacy professionals the means by which collaborative care efforts may be implemented and provider support may be generated in conjunction with initiatives such as clinical pathways and comprehensive patient management programs.
The Managed Care Review BoardTM format features multi-specialty, multi-professional managed care, and clinical specialist faculty who collaborate on the review of the clinical data, current guidelines, and economic data of a specific class of therapeutics. It uniquely provides the audience with a review of important, relevant therapeutic category information and features peer-to-peer exchange between a diverse group of managed care and clinical specialist faculty contributors. This interactive program is designed to engage the faculty and audience to develop solutions for managed care and specialty pharmacy professionals to implement within their own setting to improve outcomes for patients with MM. This approach supports managed care pharmacists by enhancing the results of their own health care organization's systematic literature reviews and analyses.
At the conclusion of this activity, participants should be able to demonstrate improved ability to:
- Evaluate recent clinical data affecting evidence-based treatment guidelines for MM
- Demonstrate the value of clinical pathways initiatives as a means of reducing treatment variability and improving clinical and economic outcomes in the management of MM
- Implement comprehensive care strategies involving effective communication methods
- Integrate innovative oncology pharmacy benefit models with specialty pharmacy management services
- Provide accurate and appropriate counsel as part of the managed care treatment team
- Provide appropriate care and counsel for patients and their families
|
Introductions and Overview |
|
Evolving Treatment Options and Clinical Benefits Update in MM
Shaji Kumar, MD |
|
Current Practice Guidelines Review and Application of Clinical Pathways John Fox, MD, MHA |
|
Faculty Idea Exchange Faculty Panel |
|
Analyzing the Available Data to Assess the Value of MM Treatment Options Diana Brixner, RPh, PhD, FAMCP Joseph Biskupiak, PhD, MBA (May 19th webcast) |
|
Plan Benefit Designs and Specialty Pharmacy Considerations in MM Jeffrey Dunn, PharmD, MBA |
| Faculty Idea Exchange, Q&A Session, Closing Commentary |
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and Impact Education, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacist Continuing Education
Accreditation Statement
 |
Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. |
Credit Designation
Postgraduate Institute for Medicine designates this continuing education activity for 2.0 contact hours (0.20 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number - (0809-9999-16-276-L01-P)
Type of Activity: Knowledge
For Pharmacists: Upon receipt of a completed activity evaluation form, ACPE credit will be uploaded to the CPE Monitor. Log into your NAPB account within 4-6 weeks of the activity date to ensure your credit has posted.
Nursing Continuing Education
Credit Designation
This educational activity for 2.0 contact hours is provided by Postgraduate Institute for Medicine.
Nursing Accreditation Statement
Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.
Hardware/Software Requirements
Compatible with Internet Explorer 6 and up, Mozilla Firefox 3 and up, Safari 4.0, and Google Chrome 10 and up
Policy on Privacy and Confidentiality
Please see final activity for the policy on privacy and confidentiality that relates to this internet activity.
Fee Information
There is no fee for this educational activity.
If you have any questions, please call (215) 619-8812 or email info@impactedu.net.